Synthesis and pharmacological characterization of some benzazepinone derivatives. 1995

R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
Department of Pharmaceutical Sciences, University of Bologna, Italy.

A series of some benzazepinone derivatives were prepared. The compounds were evaluated for inotropic, chronotropic and calcium antagonist properties. For the compounds bearing well-known alpha-blocking fragments, the antagonist potency at postsynaptic alpha-adrenoceptors was assessed. The new compounds were less effective as bradycardic agents and calcium antagonists but show remarkable negative inotropic activity.

UI MeSH Term Description Entries
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
May 2014, European journal of medicinal chemistry,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
June 1965, Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
June 1999, Farmaco (Societa chimica italiana : 1989),
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
June 1998, Farmaco (Societa chimica italiana : 1989),
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
January 1955, Rendiconti - Istituto superiore di sanita,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
November 1970, Il Farmaco; edizione scientifica,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
January 1965, Helvetica chimica acta,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
March 2023, Iranian journal of medical sciences,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
April 2003, Archiv der Pharmazie,
R Budriesi, and A Rampa, and A Bisi, and G Fabbri, and A Chiarini, and P Valenti
July 1999, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!